Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick F Sullivan

Showing results (211-220 of 468) with videos related to

Pageof 47
Sort By:
Nature Communications|June 12, 2020
mTADA is a framework for identifying risk genes from de novo mutations in multiple traitsTan-Hoang Nguyen, Amanda Dobbyn, Ruth C Brown, et al.
Alcoholism, Clinical and Experimental Research|November 23, 2006
A joint genomewide linkage analysis of symptoms of alcohol dependence and conduct disorderKenneth S Kendler, Po-Hsiu Kuo, B Todd Webb, et al.
Bioinformatics (Oxford, England)|September 6, 2007
Simulating association studies: a data-based resampling method for candidate regions or whole genome scansFred A Wright, Hanwen Huang, Xiaojun Guan, et al.
European Journal of Human Genetics : EJHG|November 6, 2014
No evidence for rare recessive and compound heterozygous disruptive variants in schizophreniaDouglas M Ruderfer, Elaine T Lim, Giulio Genovese, et al.
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
AKT1 and neurocognition in schizophreniaAndrea Poyastro Pinheiro, Richard S E Keefe, Tara Skelly, et al.
The American Journal of Psychiatry|January 8, 2020
Reproducible Genetic Risk Loci for Anxiety: Results From ∼200,000 Participants in the Million Veteran ProgramDaniel F Levey, Joel Gelernter, Renato Polimanti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 25, 2008
Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE studyIris Grossman, Patrick F Sullivan, Nicole Walley, et al.
Cells|June 25, 2026
Multimodal Proteomics Reveals Dysregulated Secretion and ECM Remodelling in Schizophrenia Patient iPSC-Derived AstrocytesWei-Ping Li, Karen E Laupman, Stephanie D Beekhuis-Hoekstra, et al.
Schizophrenia Research|March 4, 2014
Genetic modifiers and subtypes in schizophrenia: investigations of age at onset, severity, sex and family historySarah E Bergen, Colm T O'Dushlaine, Phil H Lee, et al.
Plos Genetics|April 19, 2012
Runs of homozygosity implicate autozygosity as a schizophrenia risk factorMatthew C Keller, Matthew A Simonson, Stephan Ripke, et al.
Pageof 47

Showing results (211-220 of 468) with videos related to

Sort By:
Pageof 47
Nature Communications|June 12, 2020
mTADA is a framework for identifying risk genes from de novo mutations in multiple traitsTan-Hoang Nguyen, Amanda Dobbyn, Ruth C Brown, et al.
Alcoholism, Clinical and Experimental Research|November 23, 2006
A joint genomewide linkage analysis of symptoms of alcohol dependence and conduct disorderKenneth S Kendler, Po-Hsiu Kuo, B Todd Webb, et al.
Bioinformatics (Oxford, England)|September 6, 2007
Simulating association studies: a data-based resampling method for candidate regions or whole genome scansFred A Wright, Hanwen Huang, Xiaojun Guan, et al.
European Journal of Human Genetics : EJHG|November 6, 2014
No evidence for rare recessive and compound heterozygous disruptive variants in schizophreniaDouglas M Ruderfer, Elaine T Lim, Giulio Genovese, et al.
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
AKT1 and neurocognition in schizophreniaAndrea Poyastro Pinheiro, Richard S E Keefe, Tara Skelly, et al.
The American Journal of Psychiatry|January 8, 2020
Reproducible Genetic Risk Loci for Anxiety: Results From ∼200,000 Participants in the Million Veteran ProgramDaniel F Levey, Joel Gelernter, Renato Polimanti, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 25, 2008
Genetic determinants of variable metabolism have little impact on the clinical use of leading antipsychotics in the CATIE studyIris Grossman, Patrick F Sullivan, Nicole Walley, et al.
Cells|June 25, 2026
Multimodal Proteomics Reveals Dysregulated Secretion and ECM Remodelling in Schizophrenia Patient iPSC-Derived AstrocytesWei-Ping Li, Karen E Laupman, Stephanie D Beekhuis-Hoekstra, et al.
Schizophrenia Research|March 4, 2014
Genetic modifiers and subtypes in schizophrenia: investigations of age at onset, severity, sex and family historySarah E Bergen, Colm T O'Dushlaine, Phil H Lee, et al.
Plos Genetics|April 19, 2012
Runs of homozygosity implicate autozygosity as a schizophrenia risk factorMatthew C Keller, Matthew A Simonson, Stephan Ripke, et al.
Pageof 47